US Patent Issued to TAE Life Sciences on June 3 for "Dosage unit form(s) comprising BTS and BTS(OMe) for use in boron neutron capture therapy and methods thereof" (California Inventors)

ALEXANDRIA, Va., June 4 -- United States Patent no. 12,319,707, issued on June 3, was assigned to TAE Life Sciences LLC (Irvine, Calif.).

"Dosage unit form(s) comprising BTS and BTS(OMe) for use in boron neutron capture therapy and methods thereof" was invented by Michael Y. Torgov (Redondo Beach, Calif.) and Tioga J. Martin (Los Angeles).

According to the abstract* released by the U.S. Patent & Trademark Office: "Borylated Amino Acid compositions comprising tyrosine derivatives BTS and BTS(OMe) and novel methods of making BTS and BTS(OMe) are disclosed herein. Consequently, the BTS and/or BTS(OMe) can be scaled up to commercial scale and administered to patients as a Neutron Capture Agent and provide a method of treating cancer, immunolo...